Equities

Qingdao Vland Biotech INC

603739:SHH

Qingdao Vland Biotech INC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)14.25
  • Today's Change-0.89 / -5.88%
  • Shares traded12.54m
  • 1 Year change+2.15%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Qingdao Vland Biotech Co., Ltd. is a China-based company which mainly develops, produces and sells enzyme preparations, micro-ecology and animal health products. The Company's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The Company's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The Company mainly distributes its products in China and overseas markets.

  • Revenue in CNY (TTM)1.26bn
  • Net income in CNY66.23m
  • Incorporated2005
  • Employees1.57k
  • Location
    Qingdao Vland Biotech INCNo. 596-1Jiushui East Road, Laoshan DistrictQINGDAO 266100ChinaCHN
  • Phone+86 53 288978071
  • Fax+86 53 288966609
  • Websitehttp://www.vlandgroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Xinjiang Bai Hua Cun Pharma Tech Co Ltd394.19m19.23m2.84bn787.00147.213.83--7.190.05030.05031.031.930.3631.631.77500,882.401.77-4.592.50-6.2446.2924.094.88-18.401.46--0.0006--5.54-2.50137.33---21.00--
Qingdao Vland Biotech INC1.26bn66.23m3.61bn1.57k54.172.09--2.850.26310.26315.026.830.4253.783.76805,143.803.255.785.097.8944.9846.137.6510.340.924811.630.290433.593.078.0515.56-0.650724.68-6.89
Hinova Pharmaceuticals Inc109.74k-210.18m3.75bn179.00--3.05--34,214.25-2.12-2.120.001112.440.000077.120.0805613.07-14.10-31.86-15.71-37.18-450.31---191,529.30-25,578.246.38--0.0457---100.00--2.44--124.37--
Bide Pharmatech Co Ltd1.10bn80.03m4.04bn846.0049.542.02--3.680.89830.898312.2521.980.46080.93594.511,298,144.003.34--3.82--40.11--7.25--4.59--0.0492--30.94---24.94------
Shanghai Aladdin Biochemical Tech Co Ltd497.71m103.71m4.34bn566.0035.234.17--8.720.44390.44391.983.750.31030.38189.08879,345.607.208.838.229.6161.5761.4923.2126.853.10113.470.278145.716.5519.36-7.489.9531.41--
Jiangsu Yahong Meditech Co Ltd149.71m-403.23m4.53bn394.00--2.18--30.27-0.7074-0.70740.26273.650.059816.646.92379,971.80-16.14-15.80-17.15-16.4878.6355.32-269.87-9,445.918.97--0.0599--52,594.79---62.42--64.28--
Beijing Kawin Technol Sha-hld Co Ltd1.42bn134.34m4.70bn584.0033.632.53--3.310.81750.81758.5310.870.57361.803.272,431,971.006.495.318.526.7681.8086.0211.318.102.91--0.14143.8221.7314.8739.7121.0425.01--
Beijing Sun-Novo Pharma Research Co Ltd1.16bn221.37m5.03bn1.39k22.724.45--4.351.981.9810.3310.100.607935.951.77844,377.1011.2512.9918.7621.7053.3053.9318.5021.341.8629.920.306810.7437.7647.2218.0854.9034.77--
Shanghai Medicilon Inc984.17m-276.79m5.20bn2.42k--2.21--5.28-2.01-2.017.2317.460.30296.901.27378,525.60-8.529.34-10.6611.730.644336.71-28.1214.932.64--0.114720.18-17.6833.26-109.82--23.60--
Data as of Nov 14 2024. Currency figures normalised to Qingdao Vland Biotech INC's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.12%Per cent of shares held by top holders
HolderShares% Held
Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2024126.60k0.06%
CCB Principal Asset Management Co., Ltd.as of 29 Feb 202444.90k0.02%
Western Leadbank Fund Management Co., Ltdas of 30 Jun 202437.60k0.02%
Hwabao WP Fund Management Co., Ltd.as of 30 Jun 202416.20k0.01%
China Southern Asset Management Co., Ltd.as of 30 Jun 202411.20k0.01%
Dongxing Asset Management Co. Ltd.as of 30 Jun 20244.50k0.00%
Penghua Fund Management Co., Ltd.as of 30 Jun 20243.70k0.00%
Orient Fund Management Co., Ltd.as of 30 Jun 20243.30k0.00%
China Universal Asset Management Co., Ltd.as of 30 Jun 20241.90k0.00%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024900.000.00%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.